Category In The News

February 1, 2013 06:12 PM
Low Grade Glioma Research Workshop

In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.

January 29, 2013 06:41 PM
Into Fearless, Uncharted Territory: The Brain Cancer Expedition

Max Wallace, CEO of Accelerate Brain Cancer Cure, guest blogs for The Case Foundation about our new project that could revolutionize treatment for patients.

December 17, 2012 07:19 PM
Josh Sommer Named To Forbes' "30 Under 30" List

Josh Sommer is the founder of the Chordoma Foundation.  He is a good friend and we work closely with his organization on a variety of rare disease initiatives.

December 5, 2012 12:05 AM
Max Wallace To Speak At Dupont Summit

Max will join a panel of R&D experts to discuss "The Evolving Research Enterprise:  The Role of Foundations and Strategic Funding."

November 25, 2012 03:31 PM
Avastin Update - November, 2012

Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.

November 15, 2012 10:12 PM
ABC2 Science Salons

A Unique Opportunity To Learn About The Most Innovative New Trends In Brain Tumor Research.

November 1, 2012 03:48 PM
2012 Annual Scientific Gathering

A blog post from Max Wallace, CEO of Accelerate Brain Cancer Cure.

August 20, 2012 08:59 PM
ABC2 Fellows Program

We are pleased to launch our Fellows program for young scientific investigators.  They will examine business development and strategy issues within pharmaceutical, biotechnology, financial and philanthropic organizations.

Pages

Share |

Join us in our fight for a cure!

Twitter